Investigational Drug Information for D-glucose
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the development status for investigational drug D-glucose?
D-glucose is an investigational drug.
There have been 43 clinical trials for D-glucose.
The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2020.
The most common disease conditions in clinical trials are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, and Carcinoma. The leading clinical trial sponsors are National Cancer Institute (NCI), M.D. Anderson Cancer Center, and University of Pennsylvania.
There are thirteen US patents protecting this investigational drug and six hundred and fifty-one international patents.
Summary for D-glucose
| US Patents | 13 |
| International Patents | 651 |
| US Patent Applications | 72 |
| WIPO Patent Applications | 25 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2020-11-01) |
| Vendors | 31 |
Recent Clinical Trials for D-glucose
| Title | Sponsor | Phase |
|---|---|---|
| Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer | National Cancer Institute (NCI) | Phase 1/Phase 2 |
| Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer | Varian Medical Systems | Phase 1/Phase 2 |
| Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer | Vanderbilt-Ingram Cancer Center | Phase 1/Phase 2 |
Clinical Trial Summary for D-glucose
Top disease conditions for D-glucose
Top clinical trial sponsors for D-glucose
US Patents for D-glucose
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| D-glucose | See Plans and Pricing | Cancerous B cell treatment using substituted nucleoside derivatives | The Scripps Research Institute (La Jolla, CA) | See Plans and Pricing |
| D-glucose | See Plans and Pricing | Adhesive base material | Kowa Co., Ltd. (Nagoya, JP) | See Plans and Pricing |
| D-glucose | See Plans and Pricing | Purified mite allergen | Fumakilla Ltd. (Tokyo, JP) Hiroshima University (Hiroshima-Ken, JP) | See Plans and Pricing |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for D-glucose
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| D-glucose | Australia | AU598213 | 2005-12-06 | See Plans and Pricing |
| D-glucose | Australia | AU6613986 | 2005-12-06 | See Plans and Pricing |
| D-glucose | Denmark | DK586286 | 2005-12-06 | See Plans and Pricing |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
